Search

Your search keyword '"Galvanini G"' showing total 91 results
Start Over Author "Galvanini G"
91 results on '"Galvanini G"'

10. Response of Paget’s disease to human calcitonin in patients resistant to porcine calcitonin

Author

Cascio, V., Adami, S., Galvanini, G., Lazzaretto, R., Ferrari, M., Tartarotti, D., and Scuro, L.

Abstract

Eleven patients with Paget’s disease of bone, treated intermittently for 2–4 years with porcine calcitonin (pCT) and clinically resistant to pCT [no modifications of serum alkaline phosphatase (ALP) and urinary hydroxyproline (uHOP) during pCT administration] were treated with 0.5–0.25 mg/day of human calcitonin (hCT) for 3–6 months. Nine of our patients showed biochemical improvement during the first 2 months of treatment, with reduction in ALP and uHOP. In one patient with slightly increased ALP and uHOP, and in another one during the second treatment course, hCT treatment did not modify the biochemical indices of bone disease. However all patients, including those with biochemical resistance, experienced a remarkable diminution of bone pain, which had not been observed during previous pCT treatment courses. Therefore, hCT appears to be indicated for therapeutic use in patients who are resistant to foreign calcitonins.

Published
1984
Full Text
View/download PDF

48. Vitamin D metabolites and osteomalacia in the human Fanconi syndrome

Author

Giacomo Colussi, Me, Ferrari, Surian M, Malberti F, Rombolà G, Pontoriero G, Galvanini G, and Minetti L

Subjects
Male, Osteomalacia, Humans, Infant, Female, Middle Aged, Vitamin D, Fanconi Syndrome, Aged
Abstract

Experimental evidence suggests that renal 1 alpha-hydroxylase activity is impaired in Fanconi syndrome. We have evaluated plasma vitamin D metabolites in five patients with Fanconi syndrome, three of whom had metabolic bone disease; plasma 1,25(OH)2D3 was low in the three patients with bone disease, and normal in the two patients without a bone mineralisation defect. The data supports the hypothesis that renal 1 alpha-hydroxylase activity may be impaired in human Fanconi syndrome, and that altered vitamin D metabolism may contribute to the pathogenesis of metabolic bone disease in Fanconi syndrome.

49. Comparative study of lacidipine and nicidipine SR in the treatment of hypertension: An italian multicenter study

Author

Leonetti, G., Ambrosioni, E., Bracchetti, D., Barbaresi, F., Baronchelli, A., Basevi, D., Bertoni, L., Sandre, G., Scuro, L., Bazzato, G., Bossini, A., Cagli, V., Corea, L., Dal Palu, C., Falezza, G., Fogari, R., Galvanini, G., Ghidini, O., Giungi, F., Libretti, A., alberto zanchetti, Mazzola, C., Pasotti, C., Portioli, I., Pretolani, E., Rappelli, A., Timio, M., Tumiotto, G., and Zerbini, E.

Catalog

Books, media, physical & digital resources
See catalog results